Loading data
RCATNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 40.73 m USD | 17.84 m USD | — | 1.31 m USD | 6.43 m USD |
| Cost of revenue | 39.46 m USD | 14.16 m USD | — | 5.46 m USD | 5.5 m USD |
| Gross profit | 1.27 m USD | 3.68 m USD | — | -834.31 k USD | 925.52 k USD |
| Research and development expense | 17.89 m USD | 6.27 m USD | — | 5.6 m USD | 2.61 m USD |
| Operating profit | -66.6 m USD | -19.3 m USD | — | -26.38 m USD | — |
| Interest expense | — | 68.61 k USD | — | 122 k USD | 147.72 k USD |
| Profit before tax | -71.63 m USD | -21.53 m USD | — | — | — |
| Income tax expense | 443 k USD | 0 USD | — | — | — |
| Net income (reported basis) | -72.07 m USD | -24.05 m USD | -27.09 m USD | -27.09 m USD | -11.69 m USD |
| Basic earnings per share | -0.73 USD/share | -0.4 USD/share | — | — | — |
| Diluted earnings per share | -0.73 USD/share | -0.4 USD/share | — | — | — |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.